In a recent work, triazole-pyridine-carbamate derivatives were synthesized and evaluated as CDK9 inhibitors; among this series, St.42 (Table 7) showed potent activities against HCT116 cancer cell lines with significant activities on the CDK9 enzyme. Here, CDK9 is linked to cancer.